Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life Sci Alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Mutemi DD. et al, (2024), Vaccines (Basel), 12
Integrating vaccines and monoclonal antibodies into malaria prevention.
Taylor TE. and Osier F., (2024), Nat Med